Boston An independent LDT provider

Press releases

January 19, 2021

Chief Executive Officer, Patrik Dahlen Buys Immunovia Warrants

Read press release
January 7, 2021

Proteomic data derived from Immunovia’s IMMray™-platform allows differential diagnosis of difficult to distinguish autoimmune diseases

Read press release
December 14, 2020

Immunovia publishes link to Webinar No. 3 on IMMray™ PanCan-d: Verification Study and Clinical Use

Read press release
December 11, 2020

Immunovia to Host a Third Webinar in the Series on IMMray™ PanCan-d: Verification Study and Clinical Use

Read press release
December 7, 2020

Immunovia Announces Investor Relations Changes

Read press release
December 3, 2020

Members of Immunovia’s Board of Directors purchase shares in the company

Read press release
December 2, 2020 | REGULATORY

Invitation to telephone conference in response to Dagens Industri’s article published on December 1

Read press release
November 17, 2020 | REGULATORY

Chief Executive Officer, Patrik Dahlen Buys Immunovia Shares

Read press release
November 12, 2020 | REGULATORY

Immunovia Reports Third Quarter Interim Report January – September 2020

Read press release
November 11, 2020

CORRECTED VERSION: Nomination Committee appointed for the 2021 Annual General Meeting of Immunovia AB (Publ)

Read press release
November 10, 2020

Nomination Committee appointed for the 2021 Annual General Meeting of Immunovia AB (Publ)

Read press release
November 6, 2020

Invitation to Presentation of Immunovia´s Interim Report January – September 2020 on November 12, 2020

Read press release
1 4 5 6 7 8 23